"Flemingsberg is the place in the world you want to be if you work with NK cells. There is a strong research facility here with a world-leading research group and proximity to a clinic that really knows NK cells. We recently started the construction of a new GMP facility with an associated research laboratory of 350 square meters for our NK cell therapy. The new facility is being built at Novum in Flemingsberg and, once the facility is completed in 2022, it will give us complete control over the entire development chain."
“Our research and development has been conducted in co-operation with Karolinska Institutet and Karolinska University Hospital here in Flemingsberg, and the stimulating environment with access to leading research in the area, and the positive climate on Campus Flemingsberg encourages exciting co-operation,”
“Previously, we had offices in central Stockholm. When we needed more space to establish an integrated facility for all our activities, including production, Flemingsberg was the natural choice. The main reason for this was proximity to Karolinska University Hospital, Karolinska Institutet, Swedish Red Cross University College, and other key partners for us. Our technology also has links with the 1912 Nobel Prize, (read more on our website), so what could be more appropriate for our new address than Alfred Nobel Allé,”
“In Flemingsberg, you always have access to the advanced labs that we need as well as the facilities we need to expand.”
“We conducted our research and development in collaboration with KI and Karolinska University Hospital here in Flemingsberg – work that paved the way for our insights into what causes obesity and ultimately its treatment. The positive environment at Campus Flemingsberg encourages original thinking and collaboration and has created a stimulating environment that has been decisive for us,” says Cecilia Bergh.
“Flemingsberg is exactly the right place for us thanks to its proximity to collaboration partners and the clinical research conducted at Karolinska University Hospital. Furthermore, it’s the right place for us to grow given how Flemingsberg as a whole is flourishing and developing,” says Mathias Svahn.
In Flemingsberg, there is an opportunity for us to grow and offer a good working environment for our employees. Here are the benefits of proximity to research at Karolinska Institutet and clinical research at Karolinska University Hospital. We are also attracted by the fact that the area represents innovation and looks forward with excitement to the upcoming development and that we, together with the other Life Science companies in the area, will be an important part of the new Flemingsberg.